References
- Aggarwal, B. B., S. Shishodia, S. K. Sandur, M. K. Pandey, and G. Sethi. 2006. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 72: 1605-1621 https://doi.org/10.1016/j.bcp.2006.06.029
- Ascierto, P. A., S. Scala, G. Castello, A. Daponte, E. Simeone, A. Ottaiano, G. Beneduce, V. De Rosa, F. Izzo, M. T. Melucci, C. M. Ensor, A. W. Prestayko, F. W. Holtsberg, J. S. Bomalaski, M. A. Clark, N. Savaraj, L. G. Feun, and T. F. Logan. 2005. Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies. J. Clin. Oncol. 23: 7660-7668 https://doi.org/10.1200/JCO.2005.02.0933
- Bolotin, A., P. Wincker, S. Mauger, O. Jaillon, K. Malarme, J. Weissenbach, S. D. Ehrlich, and A. Sorokin. 2001. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 11: 731-753 https://doi.org/10.1101/gr.GR-1697R
- Chun, K.-S., H.-H. Cha, J.-W. Shin, H.-K. Na, K.-K. Park, W.-Y. Chung, and Y.-J. Surh. 2004. Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-{kappa}B. Carcinogenesis 25: 445-454 https://doi.org/10.1093/carcin/bgh021
- Coussens, L. M. and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860-867 https://doi.org/10.1038/nature01322
- Ensor, C. M., F. W. Holtsberg, J. S. Bomalaski, and M. A. Clark. 2002. Pegylated arginine deiminase (ADI-SS PEG20,000 MW) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res. 62: 5443-5450
- Gong, H., F. Zolzer, G. von Recklinghausen, W. Havers, and L. Schweigerer. 2000. Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14: 826-829 https://doi.org/10.1038/sj.leu.2401763
- Hevel, J. M., K. A. White, and M. A. Marletta. 1991. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. J. Biol. Chem. 266: 22789-22791
- Hur, H. J., K. W. Lee, H. Y. Kim, D. K. Chung, and H. J. Lee. 2006. In vitro immunopotentiating activities of cellular fractions of lactic acid bacteria isolated from kimchi and bifidobacteria. J. Microbiol. Biotechnol. 16: 661-666
- Ishihara, K. and T. Hirano. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13: 357-368 https://doi.org/10.1016/S1359-6101(02)00027-8
- Izzo, F., P. Marra, G. Beneduce, G. Castello, P. Vallone, V. De Rosa, F. Cremona, C. M. Ensor, F. W. Holtsberg, J. S. Bomalaski, M. A. Clark, C. Ng, and S. A. Curley. 2004. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/ II studies. J. Clin. Oncol. 22: 1815-1822 https://doi.org/10.1200/JCO.2004.11.120
- Kang, S. W., H. Kang, I. S. Park, S. H. Choi, K. H. Shin, Y. S. Chun, B. G. Chun, and B. H. Min. 2000. Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells. Mol. Cells 10: 331-337
- Kim, J.-E., D.-W. Jeong, and H. J. Lee. 2007. Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. Protein Expr. Purif. 53: 9-15 https://doi.org/10.1016/j.pep.2006.12.002
- Kim, J. Y., H. J. Woo, Y. S. Kim, and H. J. Lee. 2002. Screening for antiproliferative effects of cellular components from lactic acid bacteria against human cancer cell lines. Biotechnol. Lett. 24: 1431-1436 https://doi.org/10.1023/A:1019875204323
- Kim, N. and G. E. Ji. 2006. Modulatory activity of Bifidobacterium sp. BGN4 cell fractions on immune cells. J Microbiol. Biotechnol. 16: 584-589
- Kim, S. Y., K. W. Lee, J. Y. Kim, and H. J. Lee. 2004. Cytoplasmic fraction of Lactococcus lactis ssp. lactis induces apoptosis in SNU-1 stomach adenocarcinoma cells. Biofactors 22: 119-122 https://doi.org/10.1002/biof.5520220123
- Kurz, S. and D. G. Harrison. 1997. Insulin and the arginine paradox. J. Clin. Invest. 99: 369-370 https://doi.org/10.1172/JCI119166
- Lechner, M., P. Lirk, and J. Rieder. 2005. Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin. Semin. Cancer Biol. 15: 277-289
- Lee, J., H. Ryu, R. J. Ferrante, S. M. Morris Jr., and R. R. Ratan. 2003. From the cover: Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. USA 100: 4843-4848
- Lee, K. H., Y. C. Lee, T. I. Kim, S. H. Noh, J. Y. Kim, H. D. Paik, and C. H. Kim. 2006. Inhibitory effect of capsaicin on interleukin-8 production by Helicobacter pyloriinfected MKN-45 cells. J. Microbiol. Biotechnol. 16: 1078-1083
-
Lee, K. W., J. H. Kim, H. J. Lee, and Y. J. Surh. 2005. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-
$\kappa$ B transcriptional activity in MCF10A human breast epithelial cells. Antioxid. Redox Signal. 7: 1612-1620 https://doi.org/10.1089/ars.2005.7.1612 - Lu, H., W. Ouyang, and C. Huang. 2006. Inflammation, a key event in cancer development. Mol. Cancer Res. 4: 221-233 https://doi.org/10.1158/1541-7786.MCR-05-0261
- Morris, S. M. Jr. 2006. Arginine: Beyond protein. Am. J. Clin. Nutr. 83: 508S-512S
- Naka, T., N. Nishimoto, and T. Kishimoto. 2002. The paradigm of IL-6: From basic science to medicine. Arthritis Res. 4 Suppl 3: S233-S242 https://doi.org/10.1186/ar412
- Noh, E. J., S. W. Kang, Y. J. Shin, D. C. Kim, I. S. Park, M. Y. Kim, B. G. Chun, and B. H. Min. 2002. Characterization of mycoplasma arginine deiminase expressed in E. coli and its inhibitory regulation of nitric oxide synthesis. Mol. Cells 13: 137-143
-
Park, C. Y., S. S. Lee, and D. K. Rhee. 2006. Effect of aluminum on TNF-
$\alpha$ secretion from murine RAW264.7 cells for endotoxin detection in hepatitis B vaccines. J. Microbiol. Biotechnol. 16: 219-225 - Persoons, J. H., K. Schornagel, F. F. Tilders, J. De Vente, F. Berkenbosch, and G. Kraal. 1996. Alveolar macrophages autoregulate IL-1 and IL-6 production by endogenous nitric oxide. Am. J. Respir. Cell Mol. Biol. 14: 272-278 https://doi.org/10.1165/ajrcmb.14.3.8845178
- Rafter, J. 2002. Lactic acid bacteria and cancer: Mechanistic perspective. Br. J. Nutr. 88 Suppl 1: S89-S94 https://doi.org/10.1079/BJN2002633
- Salvemini, D., T. P. Misko, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90: 7240-7244
- Shen, L. J., W. C. Lin, K. Beloussow, K. Hosoya, T. Terasaki, D. K. Ann, and W. C. Shen. 2003. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem. Pharmacol. 66: 1945-1952 https://doi.org/10.1016/S0006-2952(03)00555-0
- Thomas, J. B., F. W. Holtsberg, C. M. Ensor, J. S. Bomalaski, and M. A. Clark. 2002. Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin. Biochem. J. 363: 581-587 https://doi.org/10.1042/0264-6021:3630581
- Turini, M. E. and R. N. DuBois. 2002. Cyclooxygenase-2: A therapeutic target. Annu. Rev. Med. 53: 35-57 https://doi.org/10.1146/annurev.med.53.082901.103952
- Wang, D. and R. N. DuBois. 2006. Prostagladin and cancer. Gut 55: 115-122
- Warner, T. D. and J. A. Mitchell. 2004. Cyclooxygenases: New forms, new inhibitors, and lessons from the clinic. FASEB J. 18: 790-804 https://doi.org/10.1096/fj.03-0645rev
- Whan Han, J., B. G. Lee, Y. K. Kim, J. W. Yoon, H. K. Jin, S. Hong, H. Y. Lee, K. R. Lee, and H. W. Lee. 2001. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB. Br. J. Pharmacol. 133: 503-512 https://doi.org/10.1038/sj.bjp.0704099
- Won, J. H., H. T. Im, Y. H. Kim, K. J. Yun, H. J. Park, J. W. Choi, and K. T. Lee. 2006. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NFkappaB inactivation. Br. J. Pharmacol. 148: 216-225 https://doi.org/10.1038/sj.bjp.0706718
- Yoon, K., K. Soliman, and K. Redda. 2002. Inhibitory effects of N-(substituted benzoylamino)-4-ethyl-1,2,3,6- tetrahydropyridines on nitric oxide generation in stimulated raw 264.7 macrophages. Drugs Exp. Clin. Res. 28: 83-90
- Yun, J. M., H. Kwon, and J. K. Hwang. 2003. In vitro anti-inflammatory activity of panduratin A isolated from Kaempferia pandurata in RAW264.7 cells. Planta Med. 69: 1102-1108 https://doi.org/10.1055/s-2003-45190
- Zuniga, M., G. Perez, and F. Gonzalez-Candelas. 2002. Evolution of arginine deiminase (ADI) pathway genes. Mol. Phylogenet. Evol. 25: 429-444 https://doi.org/10.1016/S1055-7903(02)00277-4